Figure 1: Total number of COVID-19 cases and deaths
Figure 2: Number of COVID-19 clinical trials by start date, by month
Figure 3: Number of COVID-19 clinical trials, by multinational versus single-country
Figure 4: Single-country COVID-19 clinical trials, by region and phase
Figure 5: Multinational COVID-19 clinical trials, by region and phase
Figure 6: COVID-19 clinical trial sites, by region
Figures 7 & 8: COVID-19 clinical trial sites, by country and state
Figures 9 & 10: Number of COVID-19 clinical trials, by phase and status
Figure 11: Endpoint status for completed COVID-19 clinical trials
Figure 12: Top reasons for terminated trials, by phase
Figure 13: Top reason for terminated trials, by sponsor type
Figure 14: COVID-19 vaccine clinical trials, by trial start date
Figure 15: COVID-19 therapeutic clinical trials, by trial start date
Figures 16 & 17: Vaccine & therapeutic COVID-19 clinical trials, by phase
Figures 18 & 19: Vaccine & therapeutic COVID-19 clinical trials, by status
Figure 20: Top industry sponsors for COVID-19 vaccine clinical trials
Figure 21: Top non-industry sponsors for COVID-19 vaccine clinical trials
Figure 22: Top industry sponsors for COVID-19 therapeutic clinical trials
Figure 23: Top non-industry sponsors for COVID-19 therapeutic clinical trials
Figure 24: Long COVID clinical trials, by trial start date
Figure 25: Long COVID clinical trials, by trial status
Figure 26: Long COVID clinical trial sites, by region
Figures 27 & 28: Long COVID clinical trial sites, by country and US state
Figure 29: Long COVID clinical trials by sponsor
Figure 30: Long COVID clinical trials by drug
Figure 31: Upcoming long COVID clinical trial events
Figure 32: Clinical trials disrupted due to COVID-19
Figure 33: Disrupted clinical trials, by therapy area
Figures 34 & 35: Disrupted clinical trials activities, by region and country
Figure 36: Disrupted clinical trials, by top sponsors
Figure 37: Resumed clinical trials after being disrupted due to COVID-19, by status
Figure 38: Decentralized clinical trials, by trial start date
Figure 39: Decentralized clinical trials, by therapy area
Figure 40: Top industry sponsors for decentralized clinical trials
Figure 41: Top non-industry sponsors for decentralized clinical trials
Figure 42: Telemedicine clinical trials by trial start year
Figure 43: Number of real-world-evidence trials, by trial end date